Study Conduct

PPD launches apprenticeship for Clinical Research Associates

Thursday, March 23, 2017

Pharmaceutical Product Development (PPD) launched a clinical research associates (CRAs) apprenticeship program targeted to military veterans and military service members with medical backgrounds who are transitioning to the civilian workforce. PPD’s initiative, the first CRA apprenticeship program registered with the U.S. Department of Labor, will begin in North Carolina, Texas and California in the first quarter of this year.

[Read More]

CluePoints adds Patient Profiles to RBM and Data Quality Oversight solution

Monday, March 13, 2017

CluePoints, a provider of Risk-Based Monitoring (RBM) and Data Quality Oversight solutions for clinical trials, has introduced Patient Profiles to its rapidly expanding platform. The combination of Patient Profile reports, guided by CluePoints’ central statistical monitoring, offers a new way for clinical teams to prioritize the investigation of atypical patients in clinical trials.

[Read More]

Merz Pharmaceuticals, SAFE to launch patient-centric spasticity initiative

Tuesday, February 28, 2017

Merz Pharmaceuticals has announced the launch of Life With Spasticity, an educational online platform intended to provide comprehensive information and motivational support for stroke survivors who experience post-stroke spasticity. Designed by and for individuals living with spasticity, the project is funded by Merz and has been developed in partnership with Stroke Alliance For Europe (SAFE).

[Read More]

My Life, Our Future opens genetic hemophilia repository to scientists

Tuesday, February 28, 2017

My Life, Our Future, a national program founded by the bleeding disorder community, including Bloodworks Northwest, the American Thrombosis and Hemostasis Network, the National Hemophilia Foundation and Bioverativ, opened the largest research repository of its kind in the world to scientists. The My Life, Our Future Research Repository is a collection of genetic data and blood samples that are linked to phenotypic data from more than 5,000 people in the U.S. with hemophilia, a rare disorder that impairs the ability of one’s blood to clot. The My Life, Our Future Research Repository will allow researchers to advance the scientific understanding of the disorder, including genetic differences that affect bleeding severity and reaction to certain treatments. 

[Read More]